Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC)

Lung Cancer

Volumn 57, Issue 2, 2007, Pages 125-134

  Greco, Carlo ^a,b   Rosenzweig, Kenneth ^b   Cascini, Giuseppe Lucio ^a   Tamburrini, Oscar ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Conformal radiotherapy; Dose escalation; Functional imaging; Inter observer variability; Non small cell lung cancer; PET CT scanners; Segmentation; Treatment planning

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ACCURACY; ADULT; ATELECTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OBSERVER VARIATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; TREATMENT PLANNING; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 34447255709     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.03.020     Document Type: Review

References (45)

1. Lardinois D., Weder W., Hany T.F., Kamel E.M., Korom S., Seifert B., et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348 (2003) 2500-2507
2. Mah K., Caldwell C.B., Ung Y.C., Danjoux C.E., Balogh J.M., Ganguli S.N., et al. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 52 (2002) 339-350
3. Mac Manus M.P., Hicks R.J., Ball D.L., Kalff V., Matthews J.P., Salminen E., et al. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer 92 (2001) 886-895
4. Gregoire V., Haustermans K., Geets X., Roels S., and Lonneux M. PET-based treatment planning in radiotherapy: a new standard?. J Nucl Med 48 (2007) 68S-77S
5. Sanchez-Crespo A., Andreo P., and Larsson S.A. Positron flight in human tissues and its influence on PET image spatial resolution. Eur J Nucl Med Mol Imaging 31 (2004) 44-51
6. 18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 81 (2006) 209-225
7. Schoder H., Erdi Y.E., Chao K., Gonen M., Larson S.M., and Yeung H.W. Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients. J Nucl Med 45 (2004) 559-566
8. Paulino A.C., and Johnstone P.A. FDG-PET in radiotherapy treatment planning: Pandora's box?. Int J Radiat Oncol Biol Phys 59 (2004) 4-5
9. Bradley J., Thorstad W.L., Mutic S., Miller T.R., Dehdashti F., Siegel B.A., et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 59 (2004) 78-86
10. Giraud P., Grahek D., Montravers F., Carette M.F., Deniaud-Alexandre E., Julia F., et al. CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers. Int J Radiat Oncol Biol Phys 49 (2001) 1249-1257
11. Erdi Y.E., Rosenzweig K., Erdi A.K., Macapinlac H.A., Hu Y.C., Braban L.E., et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 62 (2002) 51-60
12. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 44 (1999) 593-597
13. 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1432-1441
14. Caldwell C.B., Mah K., Skinner M., and Danjoux C.E. Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET. Int J Radiat Oncol Biol Phys 55 (2003) 1381-1393
15. 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med 46 (2005) 1342-1348
16. Ashamalla H., Rafla S., Parikh K., Mokhtar B., Goswami G., Kambam S., et al. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1016-1023
17. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?. J Nucl Med 47 (2006) 1808-1812
18. Black Q.C., Grills I.S., Kestin L.L., Wong C.Y., Wong J.W., Martinez A.A., et al. Defining a radiotherapy target with positron emission tomography. Int J Radiat Oncol Biol Phys 60 (2004) 1272-1282
19. 18F PET signals for automatic target volume definition in radiotherapy treatment planning. Radiother Oncol 80 (2006) 43-50
20. Daisne J.F., Sibomana M., Bol A., Doumont T., Lonneux M., and Gregoire V. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. Radiother Oncol 69 (2003) 247-250
21. Nestle U., Schaefer-Schuler A., Kremp S., Groeschel A., Hellwig D., Rube C., et al. Target volume definition for (18)F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 34 (2006) 453-462
22. Nehmeh S.A., Erdi Y.E., Rosenzweig K.E., Schoder H., Larson S.M., Squire O.D., et al. Reduction of respiratory motion artifacts in PET imaging of lung cancer by respiratory correlated dynamic PET: methodology and comparison with respiratory gated PET. J Nucl Med 44 (2003) 1644-1648
23. Senan S., Chapet O., Lagerwaard F.J., and Ten Haken R.K. Defining target volumes for non-small cell lung carcinoma. Semin Radiat Oncol 14 (2004) 308-314
24. Senan S., De R.D., Giraud P., Mirimanoff R., and Budach V. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother Oncol 71 (2004) 139-146
25. 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer 19 (1998) 167-177
26. Munley M.T., Marks L.B., Scarfone C., Sibley G.S., Patz Jr. E.F., Turkington T.G., et al. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects. Lung Cancer 23 (1999) 105-114
27. Vanuytsel L.J., Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., De W.W., Verbeken E.K., et al. The impact of (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 55 (2000) 317-324
28. 18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. Q J Nucl Med Mol Imaging 49 (2005) 259-266
29. 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study. Int J Radiat Oncol Biol Phys 61 (2005) 649-655
30. De Ruysscher D., Wanders S., van H.E., Hochstenbag M., Geeraedts W., Utama I., et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys 62 (2005) 988-994
31. Ciernik I.F., Dizendorf E., Baumert B.G., Reiner B., Burger C., Davis J.B., et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 57 (2003) 853-863
32. De Ruysscher D., Wanders S., Minken A., Lumens A., Schiffelers J., Stultiens C., et al. Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study. Radiother Oncol 77 (2005) 5-10
33. Gondi V., Bradley K., Mehta M., Howard A., Khuntia D., Ritter M., et al. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 67 (2007) 187-195
34. Grills I.S., Yan D., Black Q.C., Wong C.Y., Martinez A.A., and Kestin L.L. Clinical implications of defining the gross tumor volume with combination of CT and (18)FDG-positron emission tomography in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 67 (2006) 709-719
35. Vansteenkiste J.F. Nodules, CT-scans and PET-scans: a good partnership. Lung Cancer 45 (2004) 29-30
36. 18F]fluoro-d-glucose positron emission tomography in target volume definition for radiotherapy of patients with non-small-cell lung cancer. Mol Imaging Biol 4 (2002) 257-263
37. Annema J.T., Hoekstra O.S., Smit E.F., Veselic M., Versteegh M.I., and Rabe K.F. Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA. Lung Cancer 44 (2004) 53-60
38. Senan S., and De R.D. Critical review of PET-CT for radiotherapy planning in lung cancer. Crit Rev Oncol Hematol 56 (2005) 345-351
39. Belderbos J.S., Heemsbergen W.D., De J.K., Baas P., and Lebesque J.V. Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 126-134
40. Weiss E., and Hess C.F. The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy theoretical aspects and practical experiences. Strahlenther Onkol 179 (2003) 21-30
41. Van de Steene J., Linthout N., de M.J., Vinh-Hung V., Claassens C., Noppen M., et al. Definition of gross tumor volume in lung cancer: inter-observer variability. Radiother Oncol 62 (2002) 37-49
42. 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 51 (2001) 923-931
43. Steenbakkers R.J., Duppen J.C., Fitton I., Deurloo K.E., Zijp L.J., Comans E.F., et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. Int J Radiat Oncol Biol Phys 64 (2006) 435-448
44. Fox J.L., Rengan R., O'Meara W., Yorke E., Erdi Y., Nehmeh S., et al. Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer?. Int J Radiat Oncol Biol Phys 62 (2005) 70-75
45. Graham M.V., Purdy J.A., Emami B., Harms W., Bosch W., Lockett M.A., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329